Please Wait...

Kate Adamczuk

Translation skills

Main profile

Kate Adamczuk
Kate Adamczuk, Ph.D.
Senior Scientist

Kate Adamczuk, Ph.D., is a Senior Scientist at Bioclinica. She oversees Molecular Imaging endpoints across phase I to III of multi-center neuroscience clinical trials. Her main goal is to utilize Molecular Imaging in combination with other biomarkers to facilitate the success of neuroscience clinical trials and accelerate patients’ benefits.

With more than ten years of experience in neuroscience and medical imaging, including positron emission tomography (PET), single-photon emission computerized tomography (SPECT), structural and functional magnetic resonance imaging (MRI), she develops clinical trial design strategies, serves as a scientific expert to Bioclinica clients and staff, plans and executes imaging research, and designs and assists with the implementation of processing pipelines. 

Dr. Adamczuk completed her Ph.D. in Biomedical Sciences in the Department of Neurology at the University of Leuven (KU Leuven), where she focused on amyloid PET imaging and its correlation to genetic factors, language networks, cerebrospinal fluid biomarkers, and comparison across amyloid tracers in preclinical Alzheimer’s Disease (AD), Mild Cognitive Impairment and AD patients. During her Post-Doctoral Fellowship in the Department of Neurology at the Harvard Medical School and the Massachusetts General Hospital, she extended her research to Primary Progressive Aphasia and Frontotemporal Dementia patients and added tau and fluorodeoxyglucose (FDG) PET modalities. 
 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Integration of #eTMF and #CTMS eliminates redundancies, improves workflows & enables greater study control. Join th… https://t.co/1917MtlAsA
Bioclinica (6 days ago)
Thinking of building a study in-house? Here are the 5 things you should think about before starting a DIY study bui… https://t.co/xzZWQOm49S
Bioclinica (2 weeks ago)
Integration of #eTMF and #CTMS eliminates redundancies, improves workflows & enables greater study control. Join th… https://t.co/Hoqf18zcPF
Bioclinica (2 weeks ago)
Your #IRT should not be the limiting factor during study start-up. The core features of Bioclinica's IRT agile plat… https://t.co/kitdsWvJ2S
Bioclinica (2 weeks ago)
Presenting Bioclinica CTMS: a rapid startup #CTMS that takes 2 weeks to implement, rather than months. Bioclinica C… https://t.co/tclYFoJx2z
Bioclinica (3 weeks ago)
Improve doc & study mgmt. across all studies by integrating #eTMF & #CTMS. In this webinar, Bioclinica &… https://t.co/UyoQyJVDah
Bioclinica (3 weeks ago)